DCIT Vs Tejas Networks Limited (Karnataka High Court)
AO Cannot Reclassify DSIR-Approved Scientific Research to Deny Section 35(2AB) Deduction: Karnataka HC
Introduction
The Karnataka High Court dismissed the Revenue’s appeal against relief granted to Tejas Networks Limited concerning deduction for expenditure on scientific research under Section 35(2AB) of the Income-tax Act, 1961.
The Court held that the Assessing Officer (AO) cannot undertake a merits review of DSIR-approved research expenditure by independently deciding that the underlying activities do not constitute scientific research. It also clarified that expenditure on an assessee’s own research does not become ineligible merely because it produces know-how, technology or intellectual property rights.
Facts of the Case
Tejas Networks Limited was engaged in software development, manufacturing and trading of networking equipment. It undertook research for developing optical transmission telecommunication equipment.
For AY 2009-10, the company claimed that it had incurred approximately ₹59.57 crore on research and development at its approved units. Applying the 150% deduction applicable for that assessment year, it claimed approximately ₹89.35 crore under Section 35(2AB).
The Department of Scientific and Industrial Research (DSIR) had approved its R&D facilities at JP Nagar, Bengaluru, and Ghatkopar, Mumbai. After examining the audited expenditure, DSIR issued Form 3CL dated 10 April 2013, approving expenditure of ₹4,601.95 lakh, excluding land and buildings.
The AO disallowed ₹48,41,82,071 out of the weighted deduction claimed. The Dispute Resolution Panel upheld the AO’s approach. The company successfully challenged the assessment on this limited issue before the Single Judge, following which the Revenue filed the present appeal.
Revenue’s Grounds for Disallowance
The Revenue treated expenditure relating to product development as expenditure resulting in acquisition of technology, know-how or other intangible assets.
According to the AO, expenses relating to incomplete projects represented capital work-in-progress, while completed technology yielded an enduring benefit and qualified for depreciation rather than the claimed weighted deduction.
The Revenue also relied on Section 43(4)(ii), which excludes expenditure incurred in acquiring rights in, or arising out of, scientific research. It argued that DSIR’s certification did not prevent the AO from independently examining statutory eligibility.
DSIR’s Determination Cannot Be Reopened on Merits
The High Court examined Section 35(3) and held that questions concerning whether, and to what extent, an activity constitutes scientific research fall within the jurisdiction of the prescribed authority.
The provision requires the Board to refer such questions to that authority. The AO cannot substitute an independent determination on the scientific character of activities already approved by the competent authority.
The Court therefore rejected the contention that the AO could re-examine approved expenditure by applying his own understanding of Section 43(4).
It referred to decisions including Mastek Limited and JK Synthetics Limited, supporting the prescribed authority’s statutory role in resolving disputes concerning scientific research.
Capital Expenditure Is Not Generally Excluded
The Court observed that Section 35(2AB) expressly excludes expenditure in the nature of the cost of land or buildings.
Consequently, the assumption that all capital expenditure falls outside the provision was unsustainable. Subject to the statutory conditions, expenditure on scientific research at an approved in-house facility can qualify even where it is capital in nature.
Classification as capital expenditure or the expectation of future commercial benefits did not, by themselves, justify the disputed disallowance.
Developing Intellectual Property Differs from Purchasing Existing Rights
The High Court rejected the AO’s interpretation that research expenditure becomes ineligible whenever it leads to know-how or technological advancement.
Scientific research is undertaken precisely to extend knowledge and develop technology. Treating its successful outcome as a disqualification would undermine the provision’s purpose.
The exclusion in Section 43(4)(ii) concerns expenditure on acquiring existing research rights, such as purchasing a patent from another patentee without undertaking the research oneself.
The Court distinguished such acquisition from expenditure incurred by an assessee on its own scientific research, even where that research generates proprietary rights.
AO Retains Power to Verify the Claim
The judgment does not prevent scrutiny of supporting records. The Court clarified that the AO can verify audited accounts, evidence of expenditure and the existence of necessary approvals.
The AO must also ensure that the deduction claimed remains confined to expenditure approved by the prescribed authority. Thus, the decision cannot be read as allowing the entire amount originally claimed irrespective of DSIR’s approval.
Writ Petition and Final Decision
The Court rejected the Revenue’s objection to maintainability. Availability of statutory remedies ordinarily informs judicial self-restraint; it does not remove the High Court’s jurisdiction under Article 226. Here, the dispute involved the limits of the AO’s jurisdiction.
The Revenue’s appeal was dismissed. The ruling confirms that the AO may verify a Section 35(2AB) claim but cannot independently reclassify approved research activities or deny eligibility merely because the research creates valuable intellectual property.
Cases Discussed
- Deputy CIT (Asstt.) v. Mastek Limited, Gujarat High Court, Tax Appeal No. 242/2000 and connected matters, decided 21 and 28 August 2012 — scientific research questions are for the prescribed authority.
- JK Synthetics Limited v. O.S. Bajpai, Income Tax Officer, Allahabad High Court, (1976) 105 ITR 864 — the assessing authority cannot decide the scientific research controversy itself.
- CIT v. F.C.S International Marketing (P) Limited, Punjab and Haryana High Court, citation as printed in the judgment: (2006) 155 taxmann.com 362 — reference to prescribed authority.
- Tata Hitachi Construction Machinery Company Limited v. DCIT, Bangalore ITAT, [2018] 93 taxmann.com 339 — purchasing others’ research rights distinguished from own research.
- Resil Chemicals (P) Ltd v. DCIT, Bangalore ITAT, [2014] 51 taxmann.com 250 — Section 43(4)(ii) concerns acquisition of rights from others.
